Your browser is no longer supported. Please, upgrade your browser.
Settings
PEN Penumbra, Inc. daily Stock Chart
PEN [NYSE]
Penumbra, Inc.
Index- P/E1041.80 EPS (ttm)0.13 Insider Own2.50% Shs Outstand34.08M Perf Week-0.77%
Market Cap4.54B Forward P/E114.27 EPS next Y1.17 Insider Trans-9.13% Shs Float32.43M Perf Month-15.20%
Income6.60M PEG52.09 EPS next Q0.14 Inst Own82.20% Short Float13.40% Perf Quarter-4.22%
Sales444.90M P/S10.21 EPS this Y-70.90% Inst Trans-0.14% Short Ratio11.00 Perf Half Y-2.64%
Book/sh12.28 P/B10.86 EPS next Y58.13% ROA1.30% Target Price159.33 Perf Year8.46%
Cash/sh5.89 P/C22.62 EPS next 5Y20.00% ROE1.60% 52W Range110.84 - 167.35 Perf YTD9.12%
Dividend- P/FCF236.70 EPS past 5Y44.10% ROI0.90% 52W High-19.68% Beta0.73
Dividend %- Quick Ratio4.50 Sales past 5Y38.00% Gross Margin65.70% 52W Low21.27% ATR5.26
Employees2200 Current Ratio6.20 Sales Q/Q25.70% Oper. Margin-0.20% RSI (14)41.45 Volatility4.92% 3.80%
OptionableYes Debt/Eq0.00 EPS Q/Q-74.80% Profit Margin1.50% Rel Volume0.92 Prev Close133.35
ShortableYes LT Debt/Eq0.00 EarningsMay 07 AMC Payout0.00% Avg Volume395.09K Price134.41
Recom1.80 SMA20-3.49% SMA50-7.09% SMA200-3.15% Volume228,581 Change0.80%
Oct-29-18Resumed BofA/Merrill Buy $36
Oct-08-18Initiated RBC Capital Mkts Outperform $174
Feb-21-18Initiated William Blair Outperform
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Nov-30-15Reiterated Canaccord Genuity Buy $50 → $58
Oct-13-15Initiated Wells Fargo Outperform
Apr-22-19 08:54AM  Intuitive Surgical (ISRG) Q1 Earnings, Revenues Lag Estimates Zacks
08:28AM  Edwards Lifesciences Takes Over CAS Medical Systems for $100M Zacks
Apr-19-19 09:49AM  How Penumbra, Inc. (NYSE:PEN) Could Add Value To Your Portfolio Simply Wall St.
Apr-18-19 09:25AM  Here's Why You Should Invest in Chemed (CHE) Stock Right Now Zacks
Apr-17-19 04:05PM  Penumbra, Inc. Schedules First Quarter 2019 Earnings Release and Conference Call for May 7, 2019 PR Newswire -5.63%
08:18AM  Medidata Launches Acorn Artificial Intelligence Company Zacks
Apr-16-19 07:10PM  Stryker's LIFEPAK CR2 Defibrillator Launch to Boost MedSurg Zacks
04:42PM  Here's Why You Should Buy Masimo (MASI) Stock Right Now Zacks
10:49AM  Hologic's Diagnostics Grows Strong, Escalating Costs a Woe Zacks
Apr-12-19 03:30PM  ResMed Launches AirFit P30i Nasal Pillows Mask in the US Zacks
01:29PM  Medtronic's (MDT) Study Shows Positive Results of TDD Use (revised) Zacks
Apr-11-19 09:47AM  ResMed's Brightree Widens ReSupply Solution Usage for HME Zacks
07:59AM  Walgreens Partners With VillageMD to Offer Primary Healthcare Zacks
Apr-10-19 09:48AM  Medtronic's (MDT) Study Shows Positive Results of TDD Use Zacks
09:44AM  Here's Why You Should Buy Varian Medical (VAR) Stock Now Zacks
09:39AM  Walgreens' Weak Market Trends a Woe, Strategic Deals to Aid Zacks
09:27AM  Medtronic (MDT) Inks Value-Based Deal for Guardian Connect Zacks
Apr-09-19 09:41AM  Varian Medical's (VAR) ProBeam Installed in China's HIMC Zacks
09:13AM  Bio-Rad's (BIO) IH-500 System Secures 510(K) From the FDA Zacks
Apr-08-19 10:18AM  Intersect ENT Grows on Product Launch Amid Pricing Pressure Zacks
10:13AM  Natus Medical to Divest Medix for Focusing on Core Business Zacks
09:12AM  Medtronic's New Data for HVAD System to Boost CRHF Segment Zacks
08:39AM  Orthofix (OFIX) Reports Encouraging M6-C Disc Study Results Zacks
Apr-05-19 09:40AM  Here's Why You Should Invest in DENTSPLY (XRAY) Stock Now Zacks
09:37AM  ResMed's (RMD) Brightree Unveils Analytics Platform for HME Zacks
09:33AM  Myriad Genetics Expands CDx Tie Up With AstraZeneca & Merck Zacks
09:33AM  Here's Why You Should Hold Becton, Dickinson Stock for Now Zacks
09:03AM  ABIOMED Impella Data Show Significant Rise in Survival Rates Zacks
Apr-04-19 10:45AM  ResMed (RMD) Rides on International Growth & Innovation Zacks
10:13AM  Varian Medical Opens Office in South Africa, Expands in EMEA Zacks
09:33AM  Inogen (INGN) Launches One G5 Portable Oxygen Concentrator Zacks
08:56AM  Myriad Genetics New Study Data to Lift Prenatal Tests' Uptake Zacks
Apr-03-19 10:33AM  Integra's Product Launch a Growth Catalyst, Rivalry Rife Zacks
10:32AM  AngioDynamics' (ANGO) Q3 Earnings & Revenues Lag Estimates Zacks
09:41AM  Varian Announces Halcyon's First Successful Case in Malaysia Zacks
09:41AM  Nevro (NVRO) Plagued by Issues in Australia & Stiff Rivalry Zacks
09:10AM  Bio-Rad's Latest FDA Nod to Boost Clinical Diagnostics Arm Zacks
Apr-02-19 11:07AM  Walgreens Boots (WBA) Q2 Earnings Lag Estimates, Margins Down Zacks
10:50AM  NuVasive (NUVA) Completes First COHERE XLIF Case in U.S. Zacks
10:36AM  Medtronic's Diabetes Arm Grows Strong, Rising Costs Ail Zacks
10:20AM  Glaukos (GKOS) Banks on Solid Pipeline Amid Stiff Competition Zacks
10:20AM  AngioDynamics Gets FDA Nod to Begin NanoKnife DIRECT Study Zacks
09:28AM  Amedisys Closes Oklahoma-Based RoseRock Healthcare Buyout Zacks
09:16AM  3 Reasons Why Investors Should Retain PerkinElmer (PKI) Stock Zacks
08:28AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
Apr-01-19 11:09AM  Here's Why You Should Invest in Smith & Nephew (SNN) Now Zacks
10:27AM  Globus Medical Global Base Solid, Pricing Scenario Bothers Zacks
09:10AM  Here's Why You Should Invest in ResMed (RMD) Stock Right Now Zacks
09:09AM  Genomic Health's New Positive Data to Boost Test Uptake Zacks
Mar-28-19 11:16AM  Myriad Genetics Gains on Innovation, New Reimbursements Zacks
11:13AM  ResMed (RMD) Introduces ReSupply Solution, Expands in HME Zacks
11:02AM  Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock Zacks
09:54AM  Baxter Showcases PN Product Portfolio at ASPEN Conference Zacks
Mar-27-19 10:45AM  Bruker Consistently Gains From NANO & New Strategic Buyouts Zacks
09:45AM  Medtronic Unveils MedTech Innovation Accelerator in China Zacks
Mar-26-19 08:59AM  Masimo Gets FDA Clearance for Rad-67 Monitoring Device Zacks
07:45AM  New Research: Key Drivers of Growth for Weight Watchers International, Skyworks Solutions, Chart Industries, Penumbra, Century Communities, and Continental Building Products Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-25-19 05:17PM  Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip Zacks
10:53AM  AMN Healthcare Down on Soft Locum Tenens Business, Dull View Zacks
10:42AM  Senseonics Unveils Eversense Bridge Program in the U.S. Zacks
10:04AM  Quest Diagnostics Grows on New Pacts Amid Reimbursement Issue Zacks
Mar-22-19 05:46PM  Varian (VAR) Scales New 52-Week High on Solid Prospects Zacks
03:50AM  Moving Average Crossover Alert: Penumbra Zacks
Mar-21-19 04:28PM  Here's Why You Should Hold on to Cerner (CERN) Stock for Now Zacks
07:12AM  9 High-Margin Stocks Seen Leading in Fed's New Dovish Era Investopedia
Mar-20-19 10:40AM  Stryker (SYK) Scales a New 52-Week High on Solid Prospects Zacks
Mar-19-19 10:30AM  Inogen's Prospects in Europe Solid Amid Trade-Related Tension Zacks
Mar-18-19 09:08AM  Veeva Systems (VEEV) Gains From Solid Results for Fiscal Q4 Zacks
Mar-15-19 11:01AM  Integra's Duragen Secures Japanese Nod to Drive Global Growth Zacks
Mar-14-19 09:36AM  Tandem Diabetes (TNDM) Hits a 52-Week High on Solid Prospects Zacks
Mar-12-19 04:44PM  IBD Stock Of The Day: This Medical Stock Jumps Above Key Moving Average Investor's Business Daily
09:37AM  Haemonetics' Plasma Unit Grows, Global Expansion on Track Zacks
09:24AM  Hill-Rom's Buyout of Voalte to Bolster Digital Connectivity Zacks
Mar-11-19 09:16AM  Invitae (NVTA) Scales a New 52-Week High on Solid Prospects Zacks
Mar-08-19 09:50AM  ResMed's New Brightree Suite to Boost Home Infusion Business Zacks
Mar-07-19 08:25AM  Cooper Companies (COO) Hits 52-Week High on Solid Prospects Zacks
Mar-04-19 06:38AM  Penumbra (PEN) Earnings and Revenues Beat Estimates in Q4 Zacks
Mar-01-19 08:58AM  Is Penumbras Share Price Gain Of 193% Well Earned? Simply Wall St. +5.12%
06:39AM  Edited Transcript of PEN earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 09:47AM  Integra Rides on Channel Expansion Strategy, New Alliances Zacks
09:37AM  ResMed Inks Deal With PharMerica on Medication Management Zacks
Feb-27-19 10:27AM  DexCom (DXCM) Gets Health Canada Approval for G6 CGM System Zacks -9.87%
09:29AM  Chemed Gains Ground on Solid VITAS & Roto-Rooter Businesses Zacks
Feb-26-19 08:44PM  Penumbra Inc (PEN) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:05PM  Penumbra, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results PR Newswire
02:30PM  Penumbra, Inc. to Host Earnings Call ACCESSWIRE
Feb-25-19 08:20AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
Feb-22-19 10:44AM  Quest Diagnostics Grows on Innovation Amid Reimbursement Woe Zacks
Feb-21-19 07:49AM  Masimo and Saudi Arabia MOH Collaborate for CCHD Screening Zacks
07:16AM  Luminex Hurt By Segmental Sluggishness, Stiff Competition Zacks
Feb-19-19 09:32AM  Medtronic Posts Prelim PRODIGY Outcome on Opioid Overdose Zacks
07:53AM  Align Technology Unveils iTero Element 5D Imaging System Zacks
Feb-15-19 09:33AM  Here's Why You Must Buy Cardiovascular Systems' (CSII) Stock Zacks
Feb-14-19 09:30AM  NHNKY vs. PEN: Which Stock Is the Better Value Option? Zacks
07:39AM  Here's Why Investors Should Buy CONMED (CNMD) Stock Now Zacks
Feb-13-19 08:25AM  Boston Scientific Benefits From New Buyouts & Product Launch Zacks
08:13AM  Edwards Lifesciences to Buy CASMED to Boost Critical Care Arm Zacks
Feb-12-19 08:39AM  Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock Zacks
07:07AM  Cardinal Health Strong on Pharmaceutical, Competition Rife Zacks
Feb-08-19 08:58AM  Ecolab (ECL) Reports Preliminary Q4 Results, Issues Guidance Zacks
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; and aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the JET, ACE and 3D Revascularization Device brands. It also offers neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands. In addition, the company provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; and detachable embolic coil systems for peripheral embolization under the RUBY Coil brand, as well as microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand. Further, it offers detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand, as well as a complementary device for use with RUBY Coil and POD for vessel occlusion under the POD Packing Coil brand. The company sells its products through direct sales organizations and distributors to hospitals in neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elsesser AdamChairman, CEO and PresidentApr 11Sale141.588,0001,132,6171,113,982Apr 15 08:22 PM
Kosaraju SridharCFO and Head of StrategyApr 01Sale143.455,000717,251115,750Apr 03 06:52 PM
Grewal HarpreetDirectorApr 01Sale148.4330445,12313,588Apr 03 06:49 PM
O'Rourke BridgetDirectorApr 01Sale145.7217525,5013,424Apr 03 06:45 PM
Bose AraniChief InnovatorMar 21Sale160.0755,0008,803,850577,191Mar 25 08:26 PM
Elsesser AdamChairman, CEO and PresidentMar 11Sale139.868,0001,118,8436,144Mar 13 06:18 PM
Kosaraju SridharCFO and Head of StrategyMar 11Sale139.845,000699,220120,750Mar 13 06:15 PM
Kassing Don W.DirectorJan 29Sale136.691,086148,4461,577Jan 31 07:44 PM
Grewal HarpreetDirectorJan 03Sale122.0930437,11512,943Jan 04 06:45 PM
Grewal HarpreetDirectorJan 02Sale120.5936243,65413,247Jan 04 06:45 PM
Wilder ThomasDirectorJan 02Sale120.5915218,3303,021Jan 04 06:47 PM
Davis Daniel DonenSee RemarksDec 27Option Exercise4.061,9397,86664,277Dec 31 05:42 PM
O'Rourke BridgetDirectorDec 03Sale142.191,200170,6302,650Dec 06 05:40 PM
Rothman LynnEVP and Chief Business OfficerNov 30Option Exercise3.984,50017,910136,819Apr 15 08:20 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryNov 07Sale150.001,000150,00045,556Nov 09 06:34 PM
Wilder ThomasDirectorOct 02Sale146.9615122,1913,173Oct 04 09:03 PM
Grewal HarpreetDirectorOct 02Sale146.9630344,52913,609Oct 03 08:41 PM
Grewal HarpreetDirectorOct 01Sale149.9436254,27813,912Oct 03 08:41 PM
Davis Daniel DonenSee RemarksSep 11Option Exercise3.988,50033,83066,287Sep 13 08:03 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 30Option Exercise22.042,37152,25718,038Aug 31 08:22 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 30Sale135.102,371320,32215,667Aug 31 08:22 PM
Pray James RobertPresident, InternationalAug 30Sale135.348,1251,099,668485,431Sep 04 08:40 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 29Option Exercise22.0462913,86316,296Aug 31 08:22 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 29Sale135.0062984,91515,667Aug 31 08:22 PM
Grewal HarpreetDirectorAug 27Sale129.331,528197,62414,274Aug 29 08:59 PM
Pray James RobertPresident, InternationalAug 27Sale130.385,925772,505493,556Aug 29 08:54 PM
Davis Daniel DonenSee RemarksAug 27Sale130.387,500977,82557,787Aug 29 08:32 PM
Pray James RobertPresident, InternationalAug 23Sale130.272,200286,594499,481Aug 27 08:48 PM
Davis Daniel DonenSee RemarksAug 20Option Exercise12.367,50092,70072,787Aug 22 07:20 PM
Davis Daniel DonenSee RemarksAug 20Sale125.057,500937,85365,287Aug 22 07:20 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 08Option Exercise22.044008,81615,667Aug 08 06:30 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 06Sale150.1610,0001,501,600152,296Aug 08 06:30 PM
Pray James RobertPresident, InternationalJul 30Sale138.348,1251,123,982501,681Aug 01 08:21 PM
Davis Daniel DonenSee RemarksJul 26Option Exercise12.367,50092,70072,787Jul 30 08:24 PM
Davis Daniel DonenSee RemarksJul 26Sale144.437,5001,083,24365,287Jul 30 08:24 PM
Pray James RobertPresident, InternationalJul 23Sale141.868,1251,152,579509,806Jul 25 06:48 PM
Davis Daniel DonenSee RemarksJul 19Option Exercise12.367,50092,70072,787Jul 23 07:00 PM
Davis Daniel DonenSee RemarksJul 19Sale139.927,5001,049,41565,287Jul 23 07:00 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryJul 16Option Exercise22.042657315,267Jul 18 06:40 PM
Wilder ThomasDirectorJul 11Sale138.5030442,1043,324Jul 13 06:59 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryJun 25Option Exercise22.042,53755,91515,241Jun 27 07:56 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryJun 15Option Exercise22.042,00044,08012,704Jun 19 06:56 PM
O'Rourke BridgetDirectorMay 25Buy156.40700109,4803,850May 30 08:28 PM
Rothman LynnEVP and Chief Business OfficerMay 09Sale150.386,000902,252132,319May 10 07:08 PM
Rothman LynnEVP and Chief Business OfficerMay 07Sale135.071,100148,577138,319May 08 07:23 PM
Rothman LynnEVP and Chief Business OfficerMay 04Sale135.044,900661,696139,419May 08 07:23 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryMay 01Option Exercise22.045,000110,20017,225May 03 08:15 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryMay 01Sale125.695,000628,45612,225May 03 08:15 PM